Human scleral diffusion of anticancer drugs from solution and nanoparticle formulation

Pharmaceutical Research

Volumn 26, Issue 5, 2009, Pages 1155-1161

  Kim, Esther S ^a,e   Durairaj, Chandrasekar ^b   Kadam, Rajendra S ^b   Lee, Sung Jin ^a,c   Mo, Yun ^d   Geroski, Dayle H ^a   Kompella, Uday B ^b   Edelhauser, Henry F ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c Soonchunhyang University   (South Korea)

^d Institute for Research Education and Training in the Addictions   (United States)

^e NONE   (United States)

Author keywords

Chemotherapeutic; Liposomes; Nanoparticles; Retinoblastoma; Transscleral

Indexed keywords

ANTINEOPLASTIC AGENT; BALANCED SALT SOLUTION; DOXORUBICIN; NANOPARTICLE; POLYGLACTIN DOXORUBICIN; UNCLASSIFIED DRUG; VINBLASTINE;

ADULT; AGED; ARTICLE; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG PENETRATION; FLUORESCENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; SCLERA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; DIFFUSION; DOXORUBICIN; FLUORESCENT DYES; HUMANS; LACTIC ACID; LIPOSOMES; MIDDLE AGED; NANOPARTICLES; PERMEABILITY; POLYGLYCOLIC ACID; SCLERA; TIME FACTORS; VINBLASTINE;

EID: 63949087499     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-009-9835-0     Document Type: Article

References (25)

1. A. L. Murphree J. G. Villablanca W. F. Deegan 3rd J. K. Sato M. Malogolowkin A. Fisher R. Parker E. Reed C. J. Gomer 1996 Chemotherapy plus local treatment in the management of intraocular retinoblastoma Arch. Ophthalmol 114 1348 1356
2. M. S. Benz I. U. Scott T. G. Murray D. Kramer S. Toledano 2000 Complications of systemic chemotherapy as treatment of retinoblastoma Arch. Ophthalmol 118 577 578
3. B. L. Gallie A. Budning G. DeBoer J. J. Thiessen G. Koren Z. Verjee V. Ling H. S. Chan 1996 Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy Arch. Ophthalmol 114 1321 1328
4. M. Chintagumpala P. Chevez-Barrios E. A. Paysse S. E. Plon R. Hurwitz 2007 Retinoblastoma: review of current management Oncologist 12 1237 1246
5. P. De Potter 2002 Current treatment of retinoblastoma Curr. Opin. Ophthalmol 13 331 336
6. D. H. Abramson C. M. Frank I. J. Dunkel 1999 A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma Ophthalmology 106 1947 1950
7. L. Lenazand J. A. Page 1976 Cardiotoxicity of adriamycin and related anthracyclines Cancer Treat. Rev 3 111 120
8. K. R. Van Quill P. K. Dioguardi C. T. Tong J. A. Gilbert T. M. Aaberg Jr. H. E. Grossniklaus H. F. Edelhauser J. M. O'Brien 2005 Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma Ophthalmology 112 1151 1158
9. T. G. Murray N. Cicciarelli J. M. O'Brien E. Hernandez R. L. Mueller B. J. Smith W. Feuer 1997 Subconjunctival carboplatin therapy and cryotherapy in the treatment of transgenic murine retinoblastoma Arch. Ophthalmol 115 1286 1290
10. A. E. Simpson J. A. Gilbert D. E. Rudnick D. H. Geroski T. M. Aaberg Jr. H. F. Edelhauser 2002 Transscleral diffusion of carboplatin: an in vitro and in vivo study Arch. Ophthalmol 120 1069 1074
11. A. Makimoto 2004 Results of treatment of retinoblastoma that has infiltrated the optic nerve, is recurrent, or has metastasized outside the eyeball Int. J. Clin. Oncol 9 7 12
12. F. Di Nicolantonio M. Neale Z. Onadim J. L. Hungerford J. L. Kingston I. A. Cree 2003 The chemosensitivity profile of retinoblastoma Recent Results Cancer Res 161 73 80
13. Physicians' Desk Reference, Vol. 55th ed, Medical Economics Company, Inc., Montvale, 2001, pp. 1986-2565.
14. R. Dhamodharan M. A. Jordan D. Thrower L. Wilson P. Wadsworth 1995 Vinblastine suppresses dynamics of individual microtubules in living interphase cells Mol. Biol. Cell 6 1215 1229
15. T. Hu Q. Le Z. Wu W. Wu 2007 Determination of doxorubicin in rabbit ocular tissues and pharmacokinetics after intravitreal injection of a single dose of doxorubicin-loaded poly-beta-hydroxybutyrate microspheres J. Pharm. Biomed. Anal 43 263 269
16. T. W. Olsen H. F. Edelhauser J. I. Lim D. H. Geroski 1995 Human scleral permeability: effects of age, cryotherapy, transscleral diode laser, and surgical thinning Investig. Ophthalmol. Vis. Sci 36 1893 1903
17. D. E. Rudnick J. S. Noonan D. H. Geroski M. R. Prausnitz H. F. Edelhauser 1999 The effect of intraocular pressure on human and rabbit scleral permeability Invest. Ophthalmol. Vis. Sci 40 3054 3058
18. J. A. Gilbert A. E. Simpson D. E. Rudnick D. H. Geroski T. M. Aaberg Jr. H. F. Edelhauser 2003 Transscleral permeability and intraocular concentrations of cisplatin from a collagen matrix J. Control. Release 89 409 417
19. A. C. Amriteand U. B. Kompella 2005 Size-dependent disposition of nanoparticles and microparticles following subconjunctival administration J. Pharm. Pharmacol 57 1555 1563
20. A. C. Amrite H. F. Edelhauser S. R. Singh U. B. Kompella 2008 Effect of circulation on the disposition and ocular tissue distribution of 20 nm nanoparticles after periocular administration Mol. Vis 14 150 160
21. J. Ambati C. S. Canakis J. W. Miller E. S. Gragoudas A. Edwards D. J. Weissgold I. Kim F. C. Delori A. P. Adamis 2000 Diffusion of high molecular weight compounds through sclera Invest. Ophthalmol. Vis. Sci 41 1181 1185
22. L. P. Cruysberg R. M. Nuijts D. H. Geroski L. H. Koole F. Hendrikse H. F. Edelhauser 2002 In vitro human scleral permeability of fluorescein, dexamethasone-fluorescein, methotrexate-fluorescein and rhodamine 6G and the use of a coated coil as a new drug delivery system J. Ocul. Pharmacol. Ther 18 559 569
23. U. B. Kompella N. Bandi S. P. Ayalasomayajula 2003 Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression Invest. Ophthalmol. Vis. Sci 44 1192 1201
24. S. P. Ayalasomayajulaand U. B. Kompella 2004 Retinal delivery of celecoxib is several-fold higher following subconjunctival administration compared to systemic administration Pharm. Res 21 1797 1804
25. M. R. Robinson S. S. Lee H. Kim S. Kim R. J. Lutz C. Galban P. M. Bungay P. Yuan N. S. Wang J. Kim K. G. Csaky 2006 A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide Exp. Eye Res 82 479 487